ProfileGDS5822 / ILMN_2851710
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 94% 95% 95% 93% 95% 96% 95% 95% 96% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1943.894
GSM1276600PDAC Late Ablation Control 2125095
GSM1276601PDAC Late Ablation Control 31437.195
GSM1276602PDAC Late Ablation 180293
GSM1276603PDAC Late Ablation 21250.895
GSM1276604PDAC Late Ablation 31666.596
GSM1303940PDAC Late Ablation_anti-CTLA4 11224.295
GSM1303941PDAC Late Ablation_anti-CTLA4 21361.295
GSM1303942PDAC Late Ablation_anti-CTLA4 31866.396